Literature DB >> 2692516

Structure-activity relationships of tetramethylpiperidine-substituted phenazines against Mycobacterium leprae in vitro.

S G Franzblau1, K E White, J F O'Sullivan.   

Abstract

In a previous study of structure-activity relationships of selected phenazines against Mycobacterium leprae in vitro, compounds containing a 2,2,6,6-tetramethylpiperidine substitution at the imino nitrogen were most active. Therefore, the effect of substitution at the para positions of the phenyl and anilino groups in tetramethylpiperidine-substituted phenazines was assessed. As determined by radiorespirometry, activity in ascending order was observed in compounds substituted with hydrogens or fluorines, ethoxy groups, methyl groups, chlorines, and bromines and correlated with partition coefficients in octanol-water.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2692516      PMCID: PMC172803          DOI: 10.1128/AAC.33.11.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  "B 663" in the treatment of leprosy. Preliminary report of a pilot trial.

Authors:  S G BROWNE; L M HOGERZEIL
Journal:  Lepr Rev       Date:  1962-01       Impact factor: 0.537

2.  In vitro and in vivo activities of macrolides against Mycobacterium leprae.

Authors:  S G Franzblau; R C Hastings
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

3.  Rapid, radiometric in vitro assay for the evaluation of the anti-leprosy activity of clofazimine and its analogues.

Authors:  A Mittal; P S Seshadri; M L Conalty; J F O'Sullivan; I Nath
Journal:  Lepr Rev       Date:  1985-06       Impact factor: 0.537

Review 4.  Chemotherapy of leprosy.

Authors:  R C Hastings; S G Franzblau
Journal:  Annu Rev Pharmacol Toxicol       Date:  1988       Impact factor: 13.820

5.  Structure-activity relationships of selected phenazines against Mycobacterium leprae in vitro.

Authors:  S G Franzblau; J F O'Sullivan
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

Review 6.  Leprosy.

Authors:  R C Hastings; T P Gillis; J L Krahenbuhl; S G Franzblau
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

7.  Rapid in vitro metabolic screen for antileprosy compounds.

Authors:  S G Franzblau; R C Hastings
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

8.  Clofazimine analogues active against a clofazimine-resistant organism.

Authors:  J F O'Sullivan; M L Conalty; N E Morrison
Journal:  J Med Chem       Date:  1988-03       Impact factor: 7.446

Review 9.  Lamprene (clofazimine) in leprosy. Basic information.

Authors:  S J Yawalkar; W Vischer
Journal:  Lepr Rev       Date:  1979-06       Impact factor: 0.537

10.  Oxidation of palmitic acid by Mycobacterium leprae in an axenic medium.

Authors:  S G Franzblau
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

  10 in total
  8 in total

1.  Use of thalidomide in leprosy.

Authors:  M Hooper
Journal:  BMJ       Date:  1991-11-30

2.  Fusidic acid is highly active against extracellular and intracellular Mycobacterium leprae.

Authors:  S G Franzblau; A N Biswas; E B Harris
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

3.  Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species.

Authors:  Takahiro Yano; Sacha Kassovska-Bratinova; J Shin Teh; Jeffrey Winkler; Kevin Sullivan; Andre Isaacs; Norman M Schechter; Harvey Rubin
Journal:  J Biol Chem       Date:  2010-12-30       Impact factor: 5.157

4.  Comparative in vitro activities of 20 fluoroquinolones against Mycobacterium leprae.

Authors:  S G Franzblau; K E White
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

5.  In vitro activities of aminoglycosides, lincosamides, and rifamycins against Mycobacterium leprae.

Authors:  S G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

6.  Drug susceptibility testing of Mycobacterium leprae in the BACTEC 460 system.

Authors:  S G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

7.  Comparison of twelve single-drug regimens for the treatment of type 2 diabetes mellitus.

Authors:  Shao-Lian Wang; Wen-Bin Dong; Xiao-Lin Dong; Wen-Min Zhu; Fang-Fang Wang; Fang Han; Xin Yan
Journal:  Oncotarget       Date:  2017-08-16

Review 8.  Activity of Riminophenazines against Mycobacterium tuberculosis: A Review of Studies that Might be Contenders for Use as Antituberculosis Agents.

Authors:  Mpelegeng Victoria Bvumbi
Journal:  ChemMedChem       Date:  2020-10-15       Impact factor: 3.540

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.